Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An update in recurrent spontaneous abortion.

Manoj Kumar Pandey1, Reena Rani, Suraksha Agrawal

  • 1Division of Molecular Immunology, Cincinnati Children's Hospital Medical Center, MLC 7021 TCH RF 5503 3333 Burnet Avenue, Cincinnati, OH, 45229-3039, USA. Manoj.Pandey@cchc.org

Archives of Gynecology and Obstetrics
|May 21, 2005
PubMed
Summary

Recurrent spontaneous abortion (RSA) involves multiple pregnancy losses. Unexplained RSA cases are often linked to immune system factors and can be treated with therapies like IVIg and antithrombotics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microbial biobanking: safeguarding the tiny treasures for sustainable human welfare.

Folia microbiologica·2026
Same author

Immune tolerance: Parallels between pregnancy and kidney transplantation.

Human immunology·2026
Same author

Insights into the Structural Coexistence of Hexameric States in Microcrystalline Insulin Formulations in the Solid State.

Molecular pharmaceutics·2026
Same author

Prevalence of Dental Caries and Its Association With Oral Hygiene Practices Among Primary School Children Aged 6-11 Years in North India: A Cross-Sectional Study.

Cureus·2026
Same author

Comparative Evaluation of Antibacterial Activity of Three Universal Bonding Agents Against Streptococcus mutans on Demineralized Dentin: An In Vitro Study.

Cureus·2026
Same author

Unravelling phenotypic variations and establishing a core collection in mungbean for accelerating the crop improvement programs.

Frontiers in plant science·2026

Area of Science:

  • Reproductive Immunology
  • Obstetrics and Gynecology

Background:

  • Recurrent spontaneous abortion (RSA) is defined as three or more consecutive pregnancy losses before 20 weeks.
  • The etiology of RSA is often multifactorial and unclear, with controversy surrounding diagnosis and treatment.
  • Known causes include genetic, anatomical, endocrine, placental, hormonal, infectious, lifestyle, environmental, psychological, and coagulation/immunoregulatory defects.

Purpose of the Study:

  • To review the multifactorial etiology of recurrent spontaneous abortion (RSA).
  • To highlight the role of unexplained immune system factors in RSA.
  • To discuss current and emerging treatment modalities for unexplained RSA.

Main Methods:

  • Literature review of established and potential causes of RSA.

Related Experiment Videos

  • Analysis of the role of autoimmune and alloimmune antibodies in pregnancy loss.
  • Examination of immunoregulatory molecules (HLA-G), cytokine patterns (Th-1), and cellular activity (NK cells) in RSA.
  • Review of therapeutic interventions for unexplained RSA.

    • Main Results:

    • While various factors contribute to RSA, a significant portion remains unexplained.
    • Autoimmune (APA, ANA, ACA, ATA, AECA) and alloimmune (APCA, Ab2, MLR-Bf) antibodies are implicated in the immunologic failure leading to abortion.
    • Alterations in HLA-G expression, Th-1 cytokines, and NK cell activity may also contribute to RSA.
    • Effective treatments for unexplained RSA include antithrombotic therapies (aspirin, heparin), intravenous immunoglobulin (IVIg), immunotherapy with paternal lymphocytes, and vitamin D3 therapy.

    Conclusions:

    • Recurrent spontaneous abortion (RSA) has diverse etiologies, with immune dysregulation playing a key role in unexplained cases.
    • Identifying specific antibodies and immune markers aids in understanding RSA.
    • Various immunomodulatory and antithrombotic therapies offer effective treatment options for women experiencing unexplained fetal loss.